Anglais
French
Marianne HADDAD HJEIJ
Faculté de pharmacie – Professeur
+961 (1) 421 000 marianne.haddadhjeij@usj.edu.lb
Marianne Haddad (PharmD, PhD)Marianne is a pharmacist and holds a PhD in pharmacology from Paris-Descartes University obtained in 2008. She has sixteen years of experience in higher education in several universities in Lebanon. Marianne was a full-time professor at the Lebanese University since 2014 and is currently a full-time professor at the Faculty of Pharmacy at Saint-Joseph University. She is involved in research activities in particular in pharmacology of the nervous system and medicinal plants.
Education
| Diplôme | Université | Pays | Année |
|---|---|---|---|
| PhD en Pharmacologie expérimentale et clinique | Université René Descartes(Paris V) | France | 2009 |
| Formation spéciale à l'expérimentation animale | Université René Descartes(Paris V) | France | 2007 |
| DEA pharmacologie experimentale et clinique | Université René Descartes(Paris V) | France | 2006 |
| Biopharmacie et Biodsiponibilité des médicaments | Saint Joseph University of Beyrouth | Lebanon | 2004 |
| Docteur en Pharmacie (Doctorat d'exercice) | Université Libanaise (UL) | Lebanon | 2003 |
Teaching at USJ
University teaching outside USJ
| University teaching outside USJ | Pays | Institution | Start date | End date |
|---|
Professional experience outside USJ
Areas of expertise
Research themes
Neuropharmacologie et pharmacologie des plantes médicinales
Publications and communications
Haddad M, Beray-Berthat V, Coqueran B, Plotkine M, Marchand-Leroux C, Margaill I. 2012.Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.2012. Fundam Clin Pharmacol, 27(4):393-401.Haddad M, Beray-Berthat V, Coqueran B, Palmier B, Szabo C, Plotkine M, Margaill I. 2008. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice. Eur J Pharmacol, 588 (1): 52-57.Haddad M, Rhinn H, Bloquel C, Coqueran B, Szabo C, Plotkine M, Scherman D, Margaill I. 2006. Anti-inflammatory effects of PJ34, a poly(ADP-ribose)polymerase inhibitor, in transient focal cerebral ischemia in mice. Br J Pharmacol, 149 (1): 23-30. Karaki N., Haddad M., Hammoud M., Kassem Z., Kanaan H., Makhour Y., Chokr A., Zein S. 2016. Structural Characteristics, Antitumor, Antibacterial Properties of Polysaccharides Essential oil, isolated from Eucalyptus Cultivated in Lebanon. World J Pharm. Sci, 4(9): 281-286. Haddad M., Zein S., Shahrour H., Hamadeh K., Karaki N. and Kanaan H. 2017. Antioxidant activity of water-soluble polysaccharides extracted from Eucalyptus cultivated in Lebanon. Asian Pac J Trop Biomed, 7(1): 930-933.Haddad M., Zein S., Shahrour H., Krivoruchko E, Chokr A. and Kanaan H. 2017. Eucalyptus oil prevents Staphylococcus Epidermidis biofilm formation. EJPMR, 4(11): 35-41.S. Chehade, M. Kobeissy, H. Kanaan and M. Haddad. 2021. Comparison between the chemical compositions and the in-vitro antidiabetic and anti-inflammatory activities of Salvia libanotica’ and Salvia officinalis’ leaves essential. EJPMR, 9 (3): 34-43.